help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 43, No. 1 97-106
doi:10.1210/jcem-43-1-97
Copyright © 1976 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOURIDES, I. A.
Right arrow Articles by MALOOF, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOURIDES, I. A.
Right arrow Articles by MALOOF, F.

Secretion of Alpha Subunit of Glycoprotein Hormones by Pituitary Adenomas

IONE A. KOURIDES, BRUCE D. WEINTRAUB, SAUL W. ROSEN, E. CHESTER RIDGWAY, BERNARD KLIMAN and FARAHE MALOOF

Thyroid and Endocrine Units, Department of Medicine Massachusetts General Hospital Harvard Medical School Boston, Massachusetts 02114 Clinical Endocrinology Branch National Institute of Arthritis, Metabolism Digestive Diseases National Institutes of Health, Bethesda, Maryland 20014

Address reprint requests to: Dr. lone A. Kourides, Thyroid Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.

In 60 patients with pituitary adenomas, the serum concentration of the alpha subunit of the glycoprotein hormones (serum alpha) was measured by a sensitive and specific radioimmunoassay. Five patients had markedly elevated serum alpha prior to therapy (range 14.5–23.0 ng/ml). These 5 patients included 2 hyperthyroid men with inappropriately high serum thyrotropin, one of whom also had acromegaly, a man with hyperprolactinemia and elevated cerebrospinal fluid alpha, a postmenopausal woman with low serum gonadotropins and hyperprolactinemia, and a man with central hypothyroidism and hypogonadism. Three of the 5 were restudied after therapy; serum alpha in these three decreased from 19.5 to 10.6, 23.0 to 2.0, and 17.0 to 12.0 ng/ml. Alpha in these 3 patients' serum eluted similarly to normal pituitary alpha by gel chromatography. The other 55 patients, including twenty with acromegaly, fifteen with galactorrhea, and two with Nelson's syndrome, had serum alpha <0.5–5.0 ng/ml. In addition, 22 patients with "empty sella" syndrome (no pituitary tumor) had alpha <0.5-5.0 ng/ml. Normal men and premenopausal women had serum alpha concentrations of <0.5–2.5 ng/ml; normal postmenopausal women, 1.0–7.0 ng/ml; and patients with primary hypothyroidism, 0.7–9.0 ng/ml.

The decreased alpha response to thyrotropin and luteinizing hormone-releasing hormones (TRH and LHRH) implied a relative autonomy of pituitary tumor alpha secretion; the mean alpha increment in the 5 patients with elevated serum alpha was 15% after TRH administration and 10% after LHRH. Normal individuals and patients with primary hypothyroidism demonstrated greater mean per cent alpha increments after TRH or LHRH.

In certain patients with an enlarged sella turcica, an elevated serum alpha with little or no increase in secretion after TRH and LHRH may suggest the presence of a pituitary tumor.

Supported by research grants from the American Philosophical Society (SC 1-9 CS 36) and the U.S. Public Health Service (AM 16791 and AM 04501).

This work appeared in part as an abstract at the 1975 Annual Meeting of the American Federation of Clinical Research, Atlantic City, NJ. (18).

Received November 21, 1975.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
P L Hanson, S J B Aylwin, J P Monson, and J M Burrin
FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomas
Eur. J. Endocrinol., March 1, 2005; 152(3): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. Tanaka, S. Kurabuchi, H. Mochida, H. Hayashi, and K. Wakabayashi
Production and Characterization of Specific Anti-peptide Antiserum Against Free {alpha}-subunit of Rat Pituitary Glycoprotein Hormones
J. Histochem. Cytochem., July 1, 1997; 45(7): 985 - 990.
[Abstract] [Full Text]


Home page
NEJMHome page
J.R. Garber and E.T. Hedley-Whyte
Case 25-1995- A 44-year-old woman with headache, blurred vision, and an intrasellar mass
N. Engl. J. Med., August 17, 1995; 333(7): 441 - 447.
[Full Text] [PDF]


Home page
ScienceHome page
M Begeot, F. Hemming, P. Dubois, Y Combarnous, M. Dubois, and M. Aubert
Induction of pituitary lactotrope differentiation by luteinizing hormone alpha subunit
Science, November 2, 1984; 226(4674): 566 - 568.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
G. C. BORST, C. EIL, and K. D. BURMAN
Euthyroid Hyperthyroxinemia
Ann Intern Med, March 1, 1983; 98(3): 366 - 378.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. C. Smallridge and C. E. Smith
Hyperthyroidism due to Thyrotropin-Secreting Pituitary Tumors: Diagnostic and Therapeutic Considerations
Arch Intern Med, March 1, 1983; 143(3): 503 - 507.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
B. D. WEINTRAUB, M. C. GERSHENGORN, I. A. KOURIDES, and H. FEIN
Inappropriate Secretion of Thyroid-Stimulating Hormone
Ann Intern Med, September 1, 1981; 95(3): 339 - 351.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society